Arbutus Biopharma (ABUS) Stock Highlights

3.44 | -1.43%

2024-11-21 04:14:27

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

Statistics

Range Today

3.42 3.54

Volume Today 626.5K

Range 1 Year

1.79 4.72

Volume 1 Year 268.93M

Range 3 Year

1.69 6.5

Volume 3 Year 1.32B

Range 10 Year

0.82 26.73

Volume 10 Year 3.17B

Highlights

Market Capitalization 710.6M (small)

Floating Shares 135.95M

Current Price 3.44

Price To Earnings -8.72

Price To Revenue 87.39

Price To Book 6.65

Earnings Per Share -0.43

Payout Ratio 0%

Performance

Latest -1.43%

1 Month -17.11%

3 Months -8.51%

6 Months +15.44%

1 Year +85.95%

3 Years +5.2%

5 Years +134.01%

10 Years -78.49%

Benchmarks

Market Capitalization

173 / 368

Gross Profits

192 / 278

Total Revenue

159 / 300

Total Rank

137 / 368

Free Cashflow

206 / 352

Performance 5 years

62 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.